The investment objective of the scheme is to generate returns, before expenses, that are commensurate with the performance of Nifty LargeMidcap 250 Total Return Index, subject to tracking error. There is no assurance or guarantee that the investment objective of the scheme would be achieved.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -4.4% | -6.08% | -3.79% | -5.28% | -5.44% | N/A | N/A | N/A | N/A | N/A | -0.8% |
| Category returns | -3.49% | -4.55% | -2.01% | -3.44% | -4% | -2.79% | 10.35% | 12.84% | 9.89% | 11.22% | N/A |
| Absolute returns | -4.4% | -6.08% | -3.79% | -5.28% | -5.44% | N/A | N/A | N/A | N/A | N/A | -1.59% |
| Rank within category | 118/216 | 147/207 | 124/199 | 101/193 | 95/184 | N/A | N/A | N/A | N/A | N/A | N/A |
| Index Funds | 2024 | 2025 | 2026 |
|---|---|---|---|
| Yearly returns | N/A | 7.06% | -7.05% |
| Q1 returns | N/A | -5.75% | -13.6% |
| Q2 returns | N/A | 11.76% | 13.09% |
| Q3 returns | N/A | -3.73% | -4.37% |
| Q4 returns | N/A | 5.57% | -0.53% |
NIL
| Alpha | -0.088859 |
| Beta | 0.9965 |
| Sharpe Ratio | -0.0740514 |
| Sortino Ratio | -0.123718 |
| R-Squared | 0.9957 |
| Tracking Error | 0.0434 |
| Downside Risk | 19.1224 |
| Std. Deviation (Annualised) | 14.2663 |
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICICI Prudential NASDAQ 100 Index Fund - Growth | -1.52% | 1.37% | 12.73% | 20.33% | 27.46% | 30.85% | 18.72% | N/A | 18.87% | 3,738.17 | 1.06 | 0.39 | Very High |
| Motilal Oswal S&P 500 Index Fund - Regular Plan - Growth | -0.5% | 1.6% | 10.19% | 15.5% | 24.15% | 26.62% | 16.54% | N/A | 19.94% | 4,584.30 | 1.04 | 0.44 | Very High |
| ICICI Prudential Nifty Pharma Index Fund - Regular Plan - Growth | -4.18% | -0.29% | 13.6% | 15.38% | 14.48% | 18.13% | N/A | N/A | 18.71% | 163.10 | 1.18 | 0.29 | Very High |
| UTI Nifty 500 Value 50 Index Fund - Regular Plan - Growth | -4.93% | -6.29% | -9.73% | -4.85% | 2.97% | 18.1% | N/A | N/A | 23.08% | 838.01 | 1.21 | 0.22 | Very High |
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - Growth | -4.3% | -1.59% | 11.56% | 11.09% | 13.2% | 17.83% | 12.7% | N/A | 14.93% | 191.85 | 1.10 | 0.32 | Very High |
| Motilal Oswal BSE Enhanced Value Index Fund - Regular Plan - Growth | -3.42% | -6.2% | -9.67% | -9.99% | -0.86% | 17.49% | N/A | N/A | 24.9% | 2,131.66 | 1.12 | 0.19 | Very High |
| Aditya Birla Sun Life Nifty Smallcap 50 Index Fund - Regular Plan - Growth | -4.83% | -1.02% | 10.76% | 12.27% | 8.48% | 15.62% | 10.2% | N/A | 15.72% | 364.19 | 1.11 | 0.18 | Very High |
| Kotak Nifty Smallcap 50 Index Fund - Regular Plan - Growth | -5.01% | -1.19% | 10.63% | 11.86% | 8.08% | 15.42% | N/A | N/A | 24.48% | 259.53 | 0.92 | 0.18 | Very High |
| ICICI Prudential Nifty Auto Index Fund - Regular Plan - Growth | -5.75% | -5.5% | -2.85% | -7.06% | -5.92% | 15.29% | N/A | N/A | 19.15% | 234.49 | 0.95 | 0.18 | Very High |
| Mirae Asset Nifty LargeMidcap 250 Index Fund - Regular Plan - Growth Current | -4.4% | -6.08% | -3.79% | -5.28% | -5.44% | N/A | N/A | N/A | -0.8% | 34.43 | 1.02 | -0.07 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Total | 0.00% | ||
Ms. Ekta Gala has over 3 years of experience as a dealer. Prior to this assignment, Ms. Ekta Gala was associated with ICICI Prudential Asset Management Company Ltd.
Mr. Ritesh Patel has over 10 years of experience in Commodities market. Prior to joining Mirae Asset Investment Managers (India) Private Limited, Mr. Patel has worked with companies like Aditya Birla Money Ltd, IIFL Securities, Ventura Securities, Choice Broking Pvt. Ltd and Waves research.
Get personalized portfolio management services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
